Back to Search
Start Over
GPR119 agonists 2009-2011.
- Source :
-
Pharmaceutical patent analyst [Pharm Pat Anal] 2012 Jul; Vol. 1 (3), pp. 285-99. - Publication Year :
- 2012
-
Abstract
- The increasing incidence of Type II diabetes mellitus worldwide continues to attract the attention and resources of the pharmaceutical industry in the pursuit of more effective therapies for blood glucose control. New approaches that compare favorably with classical medicaments while avoiding hypoglycemic episodes or waning effectiveness are paramount. Recent advances toward this end have been realized based on the biology of the glucagon like peptide-1 receptor (GLP1R). This β-cell-expressed GPCR has the ability to promote insulin release in a glucose-dependent fashion, and has been shown to elicit improved glycemic control and preservation of β-cell mass. Direct activation of GLP1R utilizing peptide mimetics has been achieved; however, attempts to access the biology of this receptor via small-molecule approaches have thus far been elusive. In this context, GPR119 has emerged as a tractable new alternative to GLP1R. GPR119 is another GPCR expressed on the β-cell, which, like GLP1R, signals in a glucose-dependent manner. Moreover, GPR119-mediated increases in GLP-1 and other incretins upon activation in the intestine further increase the insulinotropic activity of the β-cell. The early success in identifying small-molecule agonists of the GPR119 has prompted a rapid increase in the number of patent applications filed in the last few years. In this review we provide a comprehensive summary of all patent activity in this field that has appeared within the 2009-2011 timeframe.
- Subjects :
- Animals
Blood Glucose drug effects
Diabetes Mellitus, Type 2 physiopathology
Drug Design
Glucagon-Like Peptide 1 metabolism
Glucagon-Like Peptide-1 Receptor
Humans
Insulin metabolism
Insulin-Secreting Cells drug effects
Insulin-Secreting Cells metabolism
Patents as Topic
Receptors, G-Protein-Coupled metabolism
Receptors, Glucagon drug effects
Receptors, Glucagon metabolism
Diabetes Mellitus, Type 2 drug therapy
Hypoglycemic Agents pharmacology
Receptors, G-Protein-Coupled agonists
Subjects
Details
- Language :
- English
- ISSN :
- 2046-8962
- Volume :
- 1
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Pharmaceutical patent analyst
- Publication Type :
- Academic Journal
- Accession number :
- 24236842
- Full Text :
- https://doi.org/10.4155/ppa.12.33